Affordable medicines for all

The scandal of expensive medicines

In spite of advances in medical innovation, millions of people around the world suffer and die from treatable conditions because medicines are too expensive.
 
Historically this has tragically affected low and middle-income countries. But in recent years, the NHS has also struggled to pay extortionate prices and has had to turn down or ration new medicines. 
 

Corporate profits trump public health

Why are medicines so expensive? Drug companies can charge runaway prices because new drugs are protected by legal monopolies. This profit-driven model has made the pharmaceutical industry the most profitable in the world. Drug companies justify high prices by claiming they need to recoup their research and development costs. But nine of the top ten pharmaceutical companies spend more on marketing than on research and development. Also, most early-stage innovative research is publically funded. Drug companies reap the profits from publicly funded research, charging extortionate prices while patients are denied access to vital medicines.

Making sure any Covid-19 treatment is affordable for all

Over 70 potential vaccines are currently being researched and developed around the world but there's no guarantee that a vaccine will be made affordable for all.  Our campaign continues to fight to ensure that everyone is able to access any new Covid-19 vaccines or treatments that are in the pipeline. We are pushing the government to ensure that any new Covid-19 vaccine or treatments are affordable for all and reaches those who need it most. 

The UK government has so far committed £544 million towards researching a vaccine and treatments. But unless public health conditions are attached to publicly funded research, pharmaceutical giants can shut out anyone who can't afford their prices. When a vaccine is finally developed it should reach anyone who needs it, not just anyone who can afford it. 

Latest Blog Posts

$2,340 for a Covid-19 treatment?

Yesterday US pharmaceutical company, Gilead announced that they will charge an extraordinary $2,340 for a five-day treatment course for the drug remdesivir, which is being used as a treatment for Covid-19. The drug has been developed with substantial amounts of public money in the US, with a reported $70.5 million of public investment

$2,340 for a Covid-19 treatment?

Yesterday US pharmaceutical company, Gilead announced that they will charge an extraordinary $2,340 for a five-day treatment course for the drug remdesivir, which is being used as a treatment for Covid-19. The drug has been developed with substantial amounts of public money in the US, with a reported $70.5 million of public investment

Don’t be fooled by the government’s pledge to keep the NHS out of a Trump trade deal, these are just empty words

The government published its long-awaited negotiating objectives for a US-UK trade deal this week which included categorical statements that the NHS and drug prices are not on the table. But this does not represent a victory for all who want to protect our NHS.